These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 32993088

  • 21. Nephrogenic diabetes insipidus.
    Morello JP, Bichet DG.
    Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
    [Abstract] [Full Text] [Related]

  • 22. GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.
    Bichet DG.
    Eur J Endocrinol; 2020 Aug; 183(2):R29-R40. PubMed ID: 32580146
    [Abstract] [Full Text] [Related]

  • 23. Vasopressin increases S261 phosphorylation in AQP2-P262L, a mutant in recessive nephrogenic diabetes insipidus.
    Trimpert C, van den Berg DT, Fenton RA, Klussmann E, Deen PM.
    Nephrol Dial Transplant; 2012 Dec; 27(12):4389-97. PubMed ID: 22778181
    [Abstract] [Full Text] [Related]

  • 24. Mutations in the AVPR2, AVP-NPII, and AQP2 genes in Turkish patients with diabetes insipidus.
    Duzenli D, Saglar E, Deniz F, Azal O, Erdem B, Mergen H.
    Endocrine; 2012 Dec; 42(3):664-9. PubMed ID: 22644838
    [Abstract] [Full Text] [Related]

  • 25. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.
    Mortensen LA, Bistrup C, Jensen BL, Hinrichs GR.
    Am J Physiol Renal Physiol; 2020 Nov 01; 319(5):F746-F753. PubMed ID: 32924547
    [Abstract] [Full Text] [Related]

  • 26. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ, Knoers NV, van Os CH, Deen PM.
    Semin Nephrol; 2008 May 01; 28(3):252-65. PubMed ID: 18519086
    [Abstract] [Full Text] [Related]

  • 27. Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders.
    Ranieri M, Di Mise A, Tamma G, Valenti G.
    F1000Res; 2019 May 01; 8():. PubMed ID: 30800291
    [Abstract] [Full Text] [Related]

  • 28. Novel mutation of aquaporin-2 gene in a patient with congenital nephrogenic diabetes insipidus.
    Moon SS, Kim HJ, Choi YK, Seo HA, Jeon JH, Lee JE, Lee JY, Kwon TH, Kim JG, Kim BW, Lee IK.
    Endocr J; 2009 May 01; 56(7):905-10. PubMed ID: 19461158
    [Abstract] [Full Text] [Related]

  • 29. Molecular characterization of an aquaporin-2 mutation causing a severe form of nephrogenic diabetes insipidus.
    Saglar Ozer E, Moeller HB, Karaduman T, Fenton RA, Mergen H.
    Cell Mol Life Sci; 2020 Mar 01; 77(5):953-962. PubMed ID: 31302751
    [Abstract] [Full Text] [Related]

  • 30. Genetic analysis of nephrogenic diabetes insipidus patients: A study on the Iranian population.
    Ghasemi S, Mojbafan M, Talebi S, Hooman N, Hoseini R.
    Mol Genet Genomic Med; 2024 Apr 01; 12(4):e2421. PubMed ID: 38622833
    [Abstract] [Full Text] [Related]

  • 31. Genetic basis of nephrogenic diabetes insipidus.
    Hureaux M, Vargas-Poussou R.
    Mol Cell Endocrinol; 2023 Jan 15; 560():111825. PubMed ID: 36460218
    [Abstract] [Full Text] [Related]

  • 32. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
    de Mattia F, Savelkoul PJ, Kamsteeg EJ, Konings IB, van der Sluijs P, Mallmann R, Oksche A, Deen PM.
    J Am Soc Nephrol; 2005 Oct 15; 16(10):2872-80. PubMed ID: 16120822
    [Abstract] [Full Text] [Related]

  • 33. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
    Savelkoul PJ, De Mattia F, Li Y, Kamsteeg EJ, Konings IB, van der Sluijs P, Deen PM.
    Hum Mutat; 2009 Oct 15; 30(10):E891-903. PubMed ID: 19585583
    [Abstract] [Full Text] [Related]

  • 34. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV, Deen PM.
    Pediatr Nephrol; 2001 Dec 15; 16(12):1146-52. PubMed ID: 11793119
    [Abstract] [Full Text] [Related]

  • 35. Novel mutations underlying nephrogenic diabetes insipidus in Arab families.
    Carroll P, Al-Mojalli H, Al-Abbad A, Al-Hassoun I, Al-Hamed M, Al-Amr R, Butt AI, Meyer BF.
    Genet Med; 2006 Jul 15; 8(7):443-7. PubMed ID: 16845277
    [Abstract] [Full Text] [Related]

  • 36. Congenital nephrogenic diabetes insipidus: the current state of affairs.
    Wesche D, Deen PM, Knoers NV.
    Pediatr Nephrol; 2012 Dec 15; 27(12):2183-204. PubMed ID: 22427315
    [Abstract] [Full Text] [Related]

  • 37. A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.
    Zhang M, Yu Q, Chen C, Han J, Cheng B, Tian D.
    Medicine (Baltimore); 2019 Apr 15; 98(17):e15348. PubMed ID: 31027113
    [Abstract] [Full Text] [Related]

  • 38. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG, Turner M, Morin D.
    Proc Assoc Am Physicians; 1998 Apr 15; 110(5):387-94. PubMed ID: 9756088
    [Abstract] [Full Text] [Related]

  • 39. Correlation between AVPR2 mutations and urinary AQP2 excretion in patients with nephrogenic diabetes insipidus.
    Kotnik P, Battelino T, Debeljak M, Podkrajsek KT, Waldhauser F, Frøkiaer J, Nielsen S, Krzisnik C.
    J Pediatr Endocrinol Metab; 2007 Apr 15; 20(4):483-9. PubMed ID: 17550212
    [Abstract] [Full Text] [Related]

  • 40. A novel AVPR2 gene mutation in a Chinese pedigree with nephrogenic diabetes insipidus.
    Zhao Y, Li K, Chen C, Lv X, Wang Y, Ma L, Fu S, Liu J.
    Postgrad Med; 2024 Aug 15; 136(6):683-690. PubMed ID: 39041787
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.